DOI QR코드

DOI QR Code

Anticancer Properties of Icariside II in Human Oral Squamous Cell Carcinoma Cells

  • Kim, In-Ryoung (Department of Oral Anatomy, School of Dentistry, Pusan National University) ;
  • Kim, Young-Seok (Department of Oral Anatomy, School of Dentistry, Pusan National University) ;
  • Yu, Su-Bin (Department of Oral Anatomy, School of Dentistry, Pusan National University) ;
  • Kang, Hae-Mi (Department of Oral Anatomy, School of Dentistry, Pusan National University) ;
  • Kwak, Hyun-Ho (Department of Oral Anatomy, School of Dentistry, Pusan National University) ;
  • Park, Bong-Soo (Department of Oral Anatomy, School of Dentistry, Pusan National University)
  • Received : 2016.02.03
  • Accepted : 2016.02.26
  • Published : 2016.03.31

Abstract

OSCC is currently the most common malignancy of the head and neck, affecting tens of thousands of patients per year worldwide. Natural flavonoids from plants are potential sources for novel anti-cancer drugs. Icariin is the active ingredient of flavonol glycoside, which is derived from the medical plant Herba Epimedii. A metabolite of icariin, icariside II exhibits a variety of pharmacological actions, including anti-rheumatic, anti-depressant, cardiovascular protective, and immunomodulatory functions. However, the exact mechanism causing the apoptosis-inducing effect of icariside II in OSCC is still not fully understood. In the present study, we assessed the anti-cancer effect of icariside II in OSCC cell lines by measuring its effect on cell viability, cell proliferation, and mitochondria membrane potential (MMP). Icariside II treatment of OSCC cells resulted in a dose- and time-dependent decrease in cell viability. Hoechst staining indicated apoptosis in icariside II-treated HSC cells. Icariside II inhibited cell proliferation and induced apoptosis in HSC cells, with significant increases in all present parameters in HSC-4 cells. The results clearly suggested that icariside II induced apoptosis via activation of intrinsic pathways and caspase cascades in HSC-4 cell lines. The collective findings of the study suggested that Icariside II is a potential treatment for OSCC; in addition, the data could provide a basis for the development of a novel anti-cancer strategy.

Keywords

References

  1. Clayman GL, Ebihara S, Terada M, Mukai K, Goepfert H. Report of the Tenth International Symposium of the Foundation for Promotion of Cancer Research: Basic and clinical research in head and neck cancer. Japanese Journal of Clinical Oncology. 1997;27:361-368. doi: 10.1093/jjco/27.5.361.
  2. Casiglia J, Woo S. A comprehensive review of oral cancer. General dentistry. 2000;49:72-82.
  3. Bell RB, Kademani D, Homer L, Dierks EJ, Potter BE. Tongue cancer: Is there a difference in survival compared with other subsites in the oral cavity? Journal of Oral and Maxillofacial Surgery. 2007;65:229-236. doi: 10.1016/j.joms.2005.11.094.
  4. Lo WL, Kao SY, Chi LY, Wong YK, Chang RCS. Outcomes of oral squamous cell carcinoma in Taiwan after surgical therapy: Factors affecting survival. Journal of Oral and Maxillofacial Surgery. 2003;61:751-758. doi: 10.1016/S0278-2391(03)00149-6.
  5. Shintani S, Li CN, Mihara M, Klosek SK, Terakado N, Hino S, Hamakawa H. Anti-tumor effect of radiation response by combined treatment with angiogenesis inhibitor, TNP-470, in oral squamous cell carcinoma. Oral Oncology. 2006;42:66-72. doi: 10.1016/j.oraloncology.2005.06.010.
  6. Sarvothaman S, Undi RB, Pasupuleti SR, Gutti U, Gutti RK. Apoptosis: role in myeloid cell development. Blood Res. 2015;50:73-79. doi: 10.5045/br.2015.50.2.73.
  7. Tedesco I, Russo M, Bilotto S, Spagnuolo C, Scognamiglio A, Palumbo R, Nappo A, Iacomino G, Moio L, Russo GL. Dealcoholated red wine induces autophagic and apoptotic cell death in an osteosarcoma cell line. Food and Chemical Toxicology. 2013;60:377-384. doi: 10.1016/j.fct.2013.07.078.
  8. Hail N, Jr., Carter BZ, Konopleva M, Andreeff M. Apoptosis effector mechanisms: a requiem performed in different keys. Apoptosis. 2006;11:889-904. doi: 10.1007/s10495-006-6712-8.
  9. Guo H, Cui H, Peng X, Fang J, Zuo Z, Deng J, Wang X, Wu B, Chen K, Deng J. Modulation of the PI3K/Akt Pathway and Bcl-2 Family Proteins Involved in Chicken's Tubular Apoptosis Induced by Nickel Chloride (NiCl(2)). Int J Mol Sci. 2015;16:22989-23011. doi: 10.3390/ijms160922989.
  10. Ahn G, Lee W, Kim KN, Lee JH, Heo SJ, Kang N, Lee SH, Ahn CB, Jeon YJ. A sulfated polysaccharide of Ecklonia cava inhibits the growth of colon cancer cells by inducing apoptosis. EXCLI J. 2015;14:294-306. doi: 10.17179/excli2014-676.
  11. 2006;7:1006-1014.Ruan WJ, Zhou JG. Anticancer effects of Chinese herbal medicine, science or myth? Journal of Zhejiang University Science B. doi: 10.1631/jzus.2006.b1006.
  12. Hertog MG, Feskens EJ, Kromhout D, Hollman P, Katan M. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. The Lancet. 1993;342:1007-1011. doi: 10.1016/0140-6736(93)92876-u.
  13. Kumar S, Pandey AK. Chemistry and biological activities of flavonoids: an overview. The Scientific World Journal. 2013;2013:1-6. doi:10.1155/2013/162750.
  14. Pan Y, Kong LD, Li YC, Xia X, Kung HF, Jiang FX. Icariin from Epimedium brevicornum attenuates chronic mild stress-induced behavioral and neuroendocrinological alterations in male Wistar rats. Pharmacology Biochemistry and Behavior. 2007;87:130-140. doi: 10.1016/j.pbb.2007.04.009.
  15. Jian L, Haiyong Y, Yijia L. Determination of rat urinary metabolites of icariin in vivo and estrogenic activities of its metabolites on MCF-7 cells. Die Pharmazie-An International Journal of Pharmaceutical Sciences. 2005;60:120-125. doi: 10.1016/j.jpba.2004.06.021.
  16. Xia Q, Xu D, Huang Z, Liu J, Wang X, Wang X, Liu S. Preparation of icariside II from icariin by enzymatic hydrolysis method. Fitoterapia. 2010;81:437-442. doi: 10.1016/j.fitote.2009.12.006.
  17. Xu HB, Huang ZQ. Icariin enhances endothelial nitric-oxide synthase expression on human endothelial cells in vitro. Vascular pharmacology. 2007;47:18-24. doi: 10.1016/j.vph.2007.03.002.
  18. Huang C, Chen X, Guo B, Huang W, Shen T, Sun X, Xiao P, Zhou Q. Induction of apoptosis by Icariside II through extrinsic and intrinsic signaling pathways in human breast cancer MCF7 cells. Bioscience, biotechnology, and biochemistry. 2012;76:1322-1328. doi: 10.1271/bbb.120077.
  19. Zhang DC, Liu JL, Ding YB, Xia JG, Chen GY. Icariin potentiates the antitumor activity of gemcitabine in gallbladder cancer by suppressing NF-${\kappa}$B. Acta Pharmacologica Sinica. 2013;34:301-308. doi: 10.1038/aps.2012.162.
  20. Tong JS, Zhang QH, Huang X, Fu XQ, Qi ST, Wang YP, Hou Y, Sheng J, Sun Q-Y. Icaritin causes sustained ERK1/2 activation and induces apoptosis in human endometrial cancer cells. PLoS One. 2011;6:e16781. doi: 10.1371/journal.pone.0016781.
  21. Birt DF, Hendrich S, Wang W. Dietary agents in cancer prevention: flavonoids and isoflavonoids. Pharmacology & therapeutics. 2001;90:157-177. doi: 10.1016/s0163-7258(01)00137-1.
  22. Kim SH, Ahn KS, Jeong SJ, Kwon TR, Jung JH, Yun SM, Han I, Lee SG, Kim DK, Kang M, Chen CY, Lee JW, Kim SH. Janus activated kinase 2/signal transducer and activator of transcription 3 pathway mediates icariside II-induced apoptosis in U266 multiple myeloma cells. European Journal of Pharmacology. 2011;654:10-16. doi: 10.1016/j.ejphar.2010.11.032.
  23. Wu JY, Yi C, Chung HR, Wang DJ, Chang WC, Lee SY, Lin CT, Yang YC, Yang WCV. Potential biomarkers in saliva for oral squamous cell carcinoma. Oral oncology. 2010;46:226-231. doi: 10.1016/j.oraloncology.2010.01.007.
  24. Oropesa Avila M, Fernandez Vega A, Garrido Maraver J, Villanueva Paz M, De Lavera I, De La Mata M, Cordero MD, Alcocer Gomez E, Delgado Pavon A, Alvarez Cordoba M. Emerging roles of apoptotic microtubules during the execution phase of apoptosis. Cytoskeleton. 2015;72:435-446. doi: 10.1002/cm.21254.
  25. Nishida K, Yamaguchi O, Otsu K. Crosstalk between autophagy and apoptosis in heart disease. Circulation Research. 2008;103:343-351. doi: 10.1161/circresaha.108.175448.
  26. Kim SH, Ahn KS, Jeong SJ, Kwon TR, Jung JH, Yun SM, Han I, Lee SG, Kim DK, Kang M. Janus activated kinase 2/signal transducer and activator of transcription 3 pathway mediates icariside II-induced apoptosis in U266 multiple myeloma cells. European journal of pharmacology. 2011;654:10-16. doi: 10.1016/j.ejphar.2010.11.032.
  27. Lee KS, Lee HJ, Ahn KS, Kim S-H, Nam D, Kim DK, Choi DY, Ahn KS, Lu J, Kim SH. Cyclooxygenase-2/prostaglandin E 2 pathway mediates icariside II induced apoptosis in human PC-3 prostate cancer cells. Cancer letters. 2009;280:93-100. doi: 10.1016/j.canlet.2009.02.024.
  28. Harada H, Grant S. Apoptosis regulators. Reviews in clinical and experimental hematology. 2003;7:117-138.
  29. Wajant H. The Fas signaling pathway: more than a paradigm. Science. 2002;296:1635-1636. doi: 10.1126/science.1071553.
  30. Ouyang L, Shi Z, Zhao S, Wang FT, Zhou TT, Liu B, Bao JK. Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis. Cell proliferation. 2012;45:487-498. doi: 10.1111/j.1365-2184.2012.00845.x.
  31. Ghobrial IM, Witzig TE, Adjei AA. Targeting apoptosis pathways in cancer therapy. CA: A Cancer Journal for Clinicians. 2005;55:178-194. doi: 10.3322/canjclin.55.3.178.
  32. Wall DM, McCormick BA. Bacterial secreted effectors and caspase‐3 interactions. Cellular microbiology. 2014;16:1746-1756. doi: 10.1111/cmi.12368.
  33. Morales J, Li L, Fattah FJ, Dong Y, Bey EA, Patel M, Gao J, Boothman DA. Review of poly (ADP-ribose) polymerase (PARP) mechanisms of action and rationale for targeting in cancer and other diseases. Critical Reviews$^{TM}$ in Eukaryotic Gene Expression. 2014;24:15-28. doi: 10.1615/critreveukaryotgeneexpr.2013006875.
  34. Elmore S. Apoptosis: a review of programmed cell death. Toxicologic pathology. 2007;35:495-516. doi: 10.1080/01926230701320337.
  35. Nagata S, Nagase H, Kawane K, Mukae N, Fukuyama H. Degradation of chromosomal DNA during apoptosis. Cell Death & Differentiation. 2003;10:108-116. doi: 10.1038/sj.cdd.4401161.